Profile picture

Doctor Shinnosuke Kikuchi

University Hospital of Strasbourg, Strasbourg (France)
Follow
Logo ESC

Contributor content

Impact of balloon-expandable valve asymmetry index on heart failure following transcatheter aortic valve replacement
Presentation
Impact of balloon-expandable valve asymmetry index on heart failure following transcatheter aortic valve replacement
Residual shear stress following transcatheter aortic valve replacement is associated with rehospitalization for heart failure
Presentation
Residual shear stress following transcatheter aortic valve replacement is associated with rehospitalization for heart failure
Bleeding risk stratification in patients undergoing transcatheter aortic valve replacement: enhancing VARC-HBR criteria with CT-ADP as a marker of primary hemostatic disorder
Presentation
Bleeding risk stratification in patients undergoing transcatheter aortic valve replacement: enhancing VARC-HBR criteria with CT-ADP as a marker of primary hemostatic disorder
Periprocedural, early, and late outcomes following transcatheter aortic valve replacement in patients with severe aortic atheroma
Presentation
Periprocedural, early, and late outcomes following transcatheter aortic valve replacement in patients with severe aortic atheroma
Inflammatory burden index and mortality following transcatheter aortic valve replacement
Presentation
Inflammatory burden index and mortality following transcatheter aortic valve replacement
Impact of protruding and ulcerated aortic atheroma on periprocedural ischemic stroke in patients undergoing transcatheter aortic valve replacement: a comprehensive analysis
Presentation
Impact of protruding and ulcerated aortic atheroma on periprocedural ischemic stroke in patients undergoing transcatheter aortic valve replacement: a comprehensive analysis
Comparison of anti-inflammatory effects of rivaroxaban versus dabigatran in patients with non-valvular atrial fibrillation (RIVAL-AF study) -multicenter randomized study-
Presentation
Comparison of anti-inflammatory effects of rivaroxaban versus dabigatran in patients with non-valvular atrial fibrillation (RIVAL-AF study) -multicenter randomized study-

ESC 365 is supported by